Molecular characterisation of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli isolates from hospital and ambulatory patients in Germany

Epidemiology of Extended-Spectrum β-Lactamase-Producing E. coli and Vancomycin-Resistant Enterococci in the Northern Dutch–German Cross-Border Region

“…The latter was the most frequent gene among the Dutch and German hospital isolates, in concordance with previous studies (Ewers et al, 2012; Reuland et al, 2013; Pietsch et al, 2015). …”

“…A prevalence of 5.6% ESBL-producing E. coli isolates in hospitalized and ambulatory patients in Germany has been reported recently (Pietsch et al, 2015), which is slightly lower than the 7.7% observed in the present study.…”

“…The majority of the resistance genes found in our community isolates were CTX-M-1 which is broadly disseminated among animals in Europe, especially in cattle and pigs, followed by the CTX-M-15 gene, commonly associated with human origin (Reuland et al, 2013; Pietsch et al, 2015). The latter was the most frequent gene among the Dutch and German hospital isolates, in concordance with previous studies (Ewers et al, 2012; Reuland et al, 2013; Pietsch et al, 2015).…”

Real-time sampling of travelers shows intestinal colonization by multidrug-resistant bacteria to be a dynamic process with multiple transient acquisitions

“…Some reports describe ESBL-Ec ST101 [28], but none report ST34 or ST195. E. coli ST38 has been extensively reported as an ESBL-Ec strain isolated both from humans and animals [29][30][31].…”

Avaliação da eficácia de agentes fí­sicos e químicos contra biofilmes produzidos por clones de bactérias multirresistentes de importância clínica e epidemiológica no Brasil

“…Entretanto, recentemente, a identificação de cepas de Escherichia coli carreadoras de um novo mecanismo plasmidial de resistência (LIU et al, 2016), gene mcr-1, que confere resistência à colistina, desencadeou uma alerta mundial, uma vez que este antibiótico é uma das últimas opções terapêuticas para o tratamento de infecções causadas por bactérias Gramnegativas produtoras de carbapenemases (OLIVEIRA et al, 2018;ESPOSITO et al, 2017;FERNANDES et al, 2017;SELLERA et al, 2017;AL-TAWFIQ et al, 2017;JEANNOT et al, 2017;FERNANDES et al, 2016a;FERNANDES et al, 2016b;SAMPAIO;GALES, 2016 -M-15 (ALSHARAPY et al, 2018;PARK et al, 2018;NAMAEI et al, 2017;PIETSCH et al, 2017;DIAB et al, 2017;GRAHAM et al, 2016;MATHERS et al, 2015).…”